Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hasib Sidiqi

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|May 16, 2021
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021M Hasib Sidiqi, Morie A Gertz
Leukemia & Lymphoma|July 24, 2018
Daratumumab for the treatment of AL amyloidosisM Hasib Sidiqi, Morie A Gertz
Expert Review of Hematology|November 15, 2018
Venetoclax for the treatment of multiple myelomaIuliana Vaxman, M Hasib Sidiqi, Morie Gertz
Panminerva Medica|October 11, 2018
Therapy for relapsed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, David Dingli
Blood Advances|March 27, 2026
Management of relapsed/ refractory AL amyloidosisJessica Ling, M Hasib Sidiqi, Morie A Gertz
Mayo Clinic Proceedings|July 6, 2019
Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab TherapyAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz
JAMA|September 6, 2019
Joint Pain and ProteinuriaAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz
Haematologica|September 22, 2018
T-cell large granular lymphocytic leukemia and plasma cell disordersM Hasib Sidiqi, Mohammed A Aljama, David S Viswanatha, et al.
Cancers|January 11, 2022
Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled PromisesOmar Alkharabsheh, Zachary Trisel, Sunil Badami, et al.
Muscle & Nerve|March 2, 2021
Immune-mediated neuromuscular complications of graft-versus-host diseaseJacqui-Lyn Saw, M Hasib Sidiqi, Michelle L Mauermann, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|May 16, 2021
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021M Hasib Sidiqi, Morie A Gertz
Leukemia & Lymphoma|July 24, 2018
Daratumumab for the treatment of AL amyloidosisM Hasib Sidiqi, Morie A Gertz
Expert Review of Hematology|November 15, 2018
Venetoclax for the treatment of multiple myelomaIuliana Vaxman, M Hasib Sidiqi, Morie Gertz
Panminerva Medica|October 11, 2018
Therapy for relapsed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, David Dingli
Blood Advances|March 27, 2026
Management of relapsed/ refractory AL amyloidosisJessica Ling, M Hasib Sidiqi, Morie A Gertz
Mayo Clinic Proceedings|July 6, 2019
Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab TherapyAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz
JAMA|September 6, 2019
Joint Pain and ProteinuriaAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz
Haematologica|September 22, 2018
T-cell large granular lymphocytic leukemia and plasma cell disordersM Hasib Sidiqi, Mohammed A Aljama, David S Viswanatha, et al.
Cancers|January 11, 2022
Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled PromisesOmar Alkharabsheh, Zachary Trisel, Sunil Badami, et al.
Muscle & Nerve|March 2, 2021
Immune-mediated neuromuscular complications of graft-versus-host diseaseJacqui-Lyn Saw, M Hasib Sidiqi, Michelle L Mauermann, et al.
Pageof 5